Fund Holdings — Camber Capital Management LP

Total Portfolio Value:
$2.59M
Total Bought:
$465.8K
Total Sold:
$635.1K
Net Transaction:
-$169.3K
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Zimmer Biomet Holdings, Inc.(ZBH)1,925,0001,925,0000$254.1K$208.9K8.06%-$45.1K
Baxter Intl Inc5,000,0005,500,000+500,000$213.7K$184.0K7.10%-$29.7K
Medtronic plcSHS(MDT)1,850,0002,250,000+400,000$161.2K$177.1K6.83%+$15.9K
Universal Health Services, Inc.CL B(UHS)1,250,000950,000-300,000$228.1K$175.7K6.78%-$52.4K
Globus Medical, Inc.CL A(GMED)2,500,0002,500,0000$134.1K$171.2K6.61%+$37.1K
Viatris Inc.(VTRS)16,250,00015,000,000-1,250,000$194.0K$159.4K6.15%-$34.6K
Humana Inc.(HUM)0400,000+400,000$0$149.5K5.77%+$149.5K
Myriad Genetics, Inc.(MYGN)7,635,0005,500,000-2,135,000$162.8K$134.5K5.19%-$28.2K
Jazz Pharmaceuticals plcSHS USD(JAZZ)1,150,0001,150,0000$138.5K$122.7K4.74%-$15.7K
PTC Therapeutics, Inc.(PTCT)4,000,0003,500,000-500,000$116.4K$107.0K4.13%-$9.3K
Brookdale Senior Living Inc.(BKD)15,500,00015,500,0000$102.5K$105.9K4.09%+$3.4K
GSK plcADR(GSK)2,175,0002,675,000+500,000$93.2K$103.0K3.97%+$9.7K
BioMarin Pharmaceutical Inc.(BMRN)250,0001,100,000+850,000$21.8K$90.6K3.50%+$68.7K
Select Med Hldgs Corp3,400,0002,550,000-850,000$102.5K$89.4K3.45%-$13.1K
CVS Health Corporation(CVS)01,500,000+1,500,000$0$88.6K3.42%+$88.6K
Walgreens Boots Alliance Inc7,800,0007,000,000-800,000$169.2K$84.7K3.27%-$84.5K
Qiagen N.V.SHS NEW(QGEN)1,210,0001,500,000+290,000$52.0K$61.6K2.38%+$9.6K
Zimvie Inc3,250,0003,250,0000$53.6K$59.3K2.29%+$5.7K
Denali Therapeutics Inc.(DNLI)1,500,0002,000,000+500,000$30.8K$46.4K1.79%+$15.7K
Perrigo Company plcSHS(PRGO)1,520,0001,520,0000$48.9K$39.0K1.51%-$9.9K
Herbalife Ltd.(HLF)3,000,0003,000,0000$30.1K$31.2K1.20%+$1.0K
argenx SEADR(ARGX)072,000+72,000$0$31.0K1.19%+$31.0K
Sarepta Therapeutics, Inc.(SRPT)585,000150,000-435,000$75.7K$23.7K0.91%-$52.0K
Brookdale Senior Living Inc.UNIT 11 15 2025(BKD)250,000250,0000$22.7K$23.2K0.90%+$557
Bicycle Therapeutics PlcADS450,000915,000+465,000$11.2K$18.5K0.71%+$7.3K
OraSure Technologies, Inc.(OSUR)4,250,0004,250,0000$26.1K$18.1K0.70%-$8.0K
Inogen, Inc.(INGN)2,000,0002,000,0000$16.1K$16.3K0.63%+$120
MoonLake ImmunotherapeuticsCL A(MLTX)0355,000+355,000$0$15.6K0.60%+$15.6K
Anaptysbio Inc0500,000+500,000$0$12.5K0.48%+$12.5K
Replimune Group, Inc.(REPL)2,750,0001,350,000-1,400,000$22.5K$12.2K0.47%-$10.3K
Evolent Health, Inc.CL A(EVH)0625,000+625,000$0$11.9K0.46%+$11.9K
Theravance Biopharma Inc1,000,0001,000,0000$9.0K$8.5K0.33%-$490
SkinHealth Systems Inc.CL A(SKIN)3,500,0003,500,0000$15.5K$6.7K0.26%-$8.8K
Curevac N V1,750,000550,000-1,200,000$5.3K$1.9K0.07%-$3.4K
Genmab A/SADS(GMAB)50,00050,0000$1.5K$1.3K0.05%-$239
Biogen Inc.(BIIB)400,0000-400,000$86.3K$0—-$86.3K
Collegium Pharmaceutical, Inc.(COLL)852,9000-852,900$33.1K$0—-$33.1K
Peloton Interactive, Inc.CL A(PTON)4,500,0000-4,500,000$19.3K$0—-$19.3K
Puma Biotechnology, Inc.(PBYI)1,650,0000-1,650,000$8.7K$0—-$8.7K
Tenet Healthcare Corporation(THC)1,900,0000-1,900,000$199.7K$0—-$199.7K
Page 1 of 1
Camber Capital Management LP — 13F Holdings — Q2 2024 | TickerTrail